Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.

ABSTRACT:

Introduction

Rotavirus gastroenteritis (RVGE) remains a leading cause of hospitalization and death in children under five years of age in the Philippines. Rotavirus (RV) vaccination was introduced into the national immunization program (NIP) in 2012 but has since been limited to one region due to cost considerations and conflicting local cost-effectiveness estimates. Updated estimates of the cost-effectiveness of RV vaccination are required to inform prioritization of national immunization activities.

Methods

We calculated the potential costs and benefits of rotavirus vaccination over a 10-year-period (2021-2031) from a government and societal perspective, comparing four alternative rotavirus vaccines: Rotavac, Rotasiil, Rotarix and Rotateq. For each vaccine, a proportionate

SUBMITTER: Villanueva-Uy MET 

PROVIDER: S-EPMC8631456 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature